Literature DB >> 24588433

Systemic and renal haemodynamic effects of fluid bolus therapy: sodium chloride versus sodium octanoate-balanced solution.

Lu Ke1, Paolo Calzavacca2, Michael Bailey3, Clive N May2, Wei-Qin Li4, Joseph Bertolini5, Rinaldo Bellomo3.   

Abstract

BACKGROUND: Solutions with high chloride concentrations, like normal saline (NS), may adversely affect renal blood flow (RBF). We compared the systemic and renal haemodynamic effects of a bolus of NS with those of a novel isotonic solution containing a physiological concentration of chloride and sodium octanoate (SOct) in healthy conscious sheep.
METHODS: We performed an experimental double-blind cross-over animal study. After chronic pulmonary and renal artery flow probe insertion, animals were randomly assigned to receive rapid intravenous infusion (1 L over 30 minutes) of either NS or SOct. Haemodynamic parameters were recorded continuously before and after treatment.
RESULTS: NS and SOct had similar dilutional effects on the haematocrit. Both induced a short-lived increase in cardiac output (CO) and total peripheral conductance which dissipated by 60 minutes. However, SOct increased RBF more than NS (peak values, 213.4±34.3mL/min v 179.3±35.6mL/min; P < 0.001) with a greater RBF/CO ratio (peak values, 12.2%±3.7% v 10.6%±3.6%; P < 0.001).
CONCLUSIONS: NS and SOct appear to have similar systemic haemodynamic effects. However, OS significantly increases RBF compared with normal saline.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24588433

Source DB:  PubMed          Journal:  Crit Care Resusc        ISSN: 1441-2772            Impact factor:   2.159


  2 in total

1.  Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis.

Authors:  Nor'azim Mohd Yunos; Rinaldo Bellomo; Neil Glassford; Harvey Sutcliffe; Que Lam; Michael Bailey
Journal:  Intensive Care Med       Date:  2014-12-18       Impact factor: 17.440

Review 2.  Normal saline for intravenous fluid therapy in critically ill patients.

Authors:  Fei-Hu Zhou; Chao Liu; Zhi Mao; Peng-Lin Ma
Journal:  Chin J Traumatol       Date:  2018-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.